EP4255397
ORAL FORMULATIONS OF TENAPANOR
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
6.12.2021EP published:
18.2.2026EP application number:
21835087.4
EPO information:
European Patent Register
Max expiry date:
5.12.2041Expiry date:
5.12.2026
Title in English:
ORAL FORMULATIONS OF TENAPANORLanguage of the patent:
English
Timeline
Today
6.12.2021EP application
18.2.2026EP Publication
5.12.2026Expires
Owner
Name:
Ardelyx, Inc.Address:
34175 Ardenwood Blvd., Fremont, California 94555, US
Name:
AstraZeneca ABAddress:
Forskargatan 18, 151 85 Södertälje, SE
Inventor
Name:
GUNNARSSON, CeciliaAddress:
431 50 Mölndal, SE
Name:
SWENSON, MagnusAddress:
151 85 Sodertélje, SE
Name:
MATIC, HannaAddress:
151 85 Sodertélje, SE
Name:
SALOMONSSON, JohnAddress:
151 85 Sodertélje, SE
Name:
KARLSSON, EvaAddress:
151 85 Sodertélje, SE
Priority
Number:
202063199078 PDate:
4.12.2020Country:
US
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 31/00